Cardiovascular Disease Risk Factor

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-06-22
Clinical Trial Results: Early Add-On Combination of GLP-1 Receptor Agonist and SGLT2 Inhibitor in People With Cardiovascular-Kidney-Metabolic Stage 2-3
Early add-on combination of GLP-1 receptor agonist and SGLT2 inhibitor studied in adults with cardiovascular-kidney-metabolic syndrome and r…